Vaxcell-Bio Therapeutics Market Cap

Vaxcell-Bio Therapeutics has a market cap or net worth of 181.41 billion as of April 10, 2026. Its market cap has decreased by -17.82% in one year.

Market Cap

181.41B

Enterprise Value

143.36B

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

7,840.00

Market Cap Chart

Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 181.41B, an increase of 13.21%. That is a compound annual growth rate of 2.26%.

Market Cap History

Date	Market Cap	% Change
Apr 10, 2026	182.34B	-21.52%
Dec 30, 2025	232.34B	-3.12%
Dec 30, 2024	239.82B	-53.54%
Dec 28, 2023	516.20B	-0.71%
Dec 29, 2022	519.87B	-21.31%
Dec 30, 2021	660.68B	-73.75%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Sep 22, 2020	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
HLB Therapeutics	275.49B
JETEMA,	265.67B
Bioneer	262.23B
EASY BIO,Inc.	241.83B
Genexine	221.03B
MedPacto	175.83B
Macrogen	173.35B
ENCell	156.74B

Market Cap Rankings